Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vacuolating cytotoxin A (VacA) is a potent protein toxin secreted by Helicobacter pylori, a bacterium strongly linked to the development of peptic ulcers and gastric adenocarcinoma (UniProt P55981). The mature 88 kDa toxin is composed of two main domains: the N-terminal p33 domain and the C-terminal p55 domain (PubMed: 10490605). The p55 domain is essential for the toxin's ability to bind to the surface of host gastric epithelial cells, interacting with various receptors such as receptor-like protein tyrosine phosphatase beta (RPTPβ) and sphingomyelin (PubMed: 15941011). Following binding and internalization, VacA forms anion-selective channels in endosomal and mitochondrial membranes, leading to massive vacuolation, mitochondrial damage, and programmed cell death (PubMed: 22491015). Furthermore, VacA exerts immunomodulatory effects by inhibiting T-cell proliferation and activation, which facilitates chronic bacterial persistence (PubMed: 11274168). Given its critical role in H. pylori virulence, the p55 domain is a primary target for therapeutic interventions, including neutralizing antibodies and small-molecule inhibitors designed to block toxin attachment and subsequent cellular damage (PubMed: 25605869).
Inhibition of toxin binding to host cell receptors and prevention of toxin oligomerization.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vacuolating cytotoxin A p55 domain (VacA p55).